KRAS and cancer: To our knowledge, this is the first study that has shown that the role of PLEXIND1 in cancer correlates with the mutational status of KRAS. These findings elucidate a previously unknown PLEXIND1-mediated signaling pathway and a novel cause for the dual role PLEXIND1 in at least some forms of cancer growth.